Showing 651-660 of 767 results for "".
- Deucravacitinib Plus Topical C/BD Effective in Moderate to Severe Psoriasis: Analysishttps://practicaldermatology.com/news/deucravacitinib-plus-topical-cbd-effective-in-moderate-to-severe-psoriasis-analysis/2476009/New research in the Journal of Drugs in Dermatology suggests that adding topical calcipotriene/betamethasone dipropionate (C/BD) foam to oral deucravacitinib therapy improves outcomes and quality of life in patients with moderate to severe chronic plaque p
- Dr. Susan C. Taylor Elected 2025 AAD Presidenthttps://practicaldermatology.com/news/dr-susan-c-taylor-elected-2025-aad-president/2461653/Susan C. Taylor, MD, FAAD is the American Academy of Dermatology’s president-elect. She will be installed in March 2024 and hold the office of president for one year beginning in March 2025. Dr. Taylor previously served as AAD Vice President from 2020 – 2021.
- Lauren Miller, MPAS, PA-C Begins Term as SDPA Presidenthttps://practicaldermatology.com/news/lauren-miller-mpas-pa-c-begins-term-as-sdpa-president/2461267/Lauren Miller, MPAS, PA-C is president of the Society of Dermatology Physician Assistants Board of Directors. Ms. Miller, a DermPA™ with Dermatology Specialists in Gadsden, AL, will serve a one-year term leading the nine-member elected board. “I am honored and humbled t
- TruSkin SPF 30 Mineral Sunscreen with Vitamin C Launcheshttps://practicaldermatology.com/news/truskin-spf-30-mineral-sunscreen-with-vitamin-c-launches/2461245/New from TruSkin, TruSkin SPF 30 Mineral Sunscreen with Vitamin C features non-nano zinc oxide in a lightweight, non-greasy formula with asheer finish intended to blend into a
- SkinCeuticals, Aesthetics Biomedical Join Forces for Vivace Experience Featuring SkinCeuticals C E Ferulichttps://practicaldermatology.com/news/skinceuticals-aesthetics-biomedical-join-forces-for-vivace-experience-featuring-skinceuticals-c-e-ferulic/2460558/SkinCeuticals is teaming up Aesthetics Biomedical’s Vivace Fractional Micro Needle Radio Frequency Treatment to create the professional Vivace Experience featuring SkinCeuticals C E Ferulic MaryAnn Guerra, CEO & President of Aesthetics Biomedical states, "Aesth
- Jan Marini Skin Research Marks 20 Years of Innovationhttps://practicaldermatology.com/news/20140625-jan_marini_skin_research_marks_20_years_of_innovation/2459188/After 20 years, Jan Marini Skin Research (JMSR) continues to distinguish itself as a recognized leader in the professional skincare industry through its combined focus on results, new productinnovation and its commitment to clinical and medical validation. Robert Weiss, MD, conducted a st
- Study: Brepocitinib Reduces Inflammatory Markers in Cicatricial Alopeciahttps://practicaldermatology.com/news/study-brepocitinib-reduces-inflammatory-markers-in-cicatricial-alopecia/2471712/A recent phase 2a clinical trial showed brepocitinib was associated with a significant reduction in C-C motif chemokine ligand 5 (CCL5) expression and improved clinical severity scores in patients with cicatricial alopecia (CA).
- Valeant Appoints New Chief Quality Officerhttps://practicaldermatology.com/news/valeant-appoints-new-chief-quality-officer/2458416/Valeant Pharmaceuticals International, Inc. appointed Louis W. Yu, PhD to the newly created position of Chief Quality Officer, Global Quality, effective October 3, 2016. Dr. Yu reports to Joseph C. Papa, C
- Dermavant Receives Approval of Tapinarof for Psoriasis and Atopic Dermatitis in Japanhttps://practicaldermatology.com/news/dermavant-receives-approval-tapinarof-psoriasis-and-atopic-dermatitis-japan/2467170/Dermavant Sciences announced that Japan Tobacco has received approval in Japan for tapinarof c
- Arcutis, Huadong Announce Strategic Collab and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asiahttps://practicaldermatology.com/news/arcutis-huadong-announce-strategic-collab-and-licensing-agreement-for-topical-roflumilast-in-greater-china-and-southeast-asia/2461921/Arcutis Biotherapeutics, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co. have entered into a strategic c